Overview
Fund Chronology
Investment Areas
Investment Strategy
Investment Team
Brief History
Locations

Overview
ARCH Venture Partners, one of the largest early stage technology venture firms in the U.S., invests in the development of seed and early stage advanced technology companies that have the potential to grow rapidly into successful businesses. ARCH enjoys special recognition as a leader in the successful commercialization of technologies developed at academic research institutions, corporate research groups and national laboratories.

ARCH currently manages eight funds totaling $1.9 billion and has invested in the earliest venture capital rounds for more than 160 companies. Our limited partners include major corporations, pension funds, university endowments, financial institutions, and private investors.

The partnership is led by eight managing directors, including four co-founders who have worked together for more than 28 years. They are supported by a team of partners, venture partners, associates, and technology specialists.

^top

Fund Chronology
1986 ARCH Development Corp. founded, first ARCH portfolio company created
1989 ARCH Venture Fund I
1993 ARCH Venture Fund II
1996 ARCH Venture Fund III
1999 ARCH Venture Fund IV
2000 ARCH Venture Fund V
2003 ARCH Venture Fund VI
2007 ARCH Venture Fund VII
2014 ARCH Venture Fund VIII

$9 million
$31 million
$107 million
$175 million
$380 million
$350 million
$400 million
$410 million

^top

Investment Areas
ARCH concentrates on innovations in life sciences, physical sciences and information technology, and we specialize in the spaces where they converge. Technology specializations include semiconductors, advanced materials, clean technology innovations, optics and photonics, electronic components, network infrastructure and security, high performance computing, wireless communications, pharmaceuticals, genomics and bioinformatics, medical devices, diagnostic and drug discovery platforms; nano- and microtechnologies.

We are interested in technologies that are in the nascent stages of development --- nurturing technologies that are still in the laboratory is a common practice at ARCH.

^top

Investment Strategy
We are guided by seven investment principles that have proven successful through multiple funds and stable through economic cycles:

^top

Investment Team
The partnership is led by eight managing directors, including four co-founders who have worked together for more than 28 years. They are supported by a team of partners, venture partners, associates, and technology specialists.

Managing Directors
Clinton Bybee
Keith Crandell
Robert Nelsen
Steven Lazarus
Steve Gillis
Kristina Burow
Paul Thurk
Mark McDonnell

Co-founder & Managing Director
Co-founder & Managing Director
Co-founder & Managing Director
Co-founder & Managing Director, Emeritis
Managing Director
Managing Director
Managing Director
Managing Director, CFO & CAO
Venture Partners, Associates & Research Affiliates
Ken Bradley
Tom Brennan
Dan Crowley
Nathaniel David
Edgar Hotard
Hong Hou
George Kadifa
Michael Knapp
Scott Minick
Maurice Treacy
David Cruikshank
Cindy Bailey
Alex Rives
Venture Partner
Venture Partner
Venture Partner
Venture Partner
Venture Partner
Venture Partner
Venture Partner
Venture Partner
Venture Partner
Venture Partner
Vice President
Affiliate
Affiliate

^top

Brief History
ARCH Venture Partners is a spinoff from an innovative technology commercialization initiative originated by The University of Chicago. In 1986, ARCH Development Corporation was formed as a not-for-profit affiliate corporation dedicated to commercializing promising technology developed in research laboratories at Argonne National Laboratory and the University.

Steven Lazarus was recruited to lead the new organization, with the broad mandate to license promising technology and promote the formation of spinoff companies. In 1986, Robert Nelsen and Keith Crandell joined Lazarus to focus on new company formation. Together they pioneered a successful commercialization strategy that benefited both the university and the scientists behind the research.

Very importantly, they recognized the need to create a venture capital fund to support the formation of spinoff companies, as the Midwest did not support a strong early stage venture capital community at the time. Shortly thereafter, in 1989 ARCH raised its first venture fund.

In late 1992, Lazarus, Crandell, and Nelsen formed ARCH Venture Partners in a friendly separation agreement with The University of Chicago, which became a special limited partner and investor in the new venture capital firm. ARCH Development Corporation remained within the university as its technology transfer arm.

A year later, Clinton Bybee, an experienced seed investor and colleague from ARCH Development Corporation dating back to 1988, joined as ARCH's fourth partner. As a team ARCH's founding partners are unique, sharing more than 28 years of collaborative experiences in early stage new enterprise formation. This cohesive structure has been an underpinning of the firm's continuing success.

^top

Locations
ARCH maintains offices in Austin, TX, Chicago, IL, Seattle, WA, San Francisco, CA, and Dublin, Ireland. Part of our philosophy is to tap into underserved geographic markets that contain great centers of basic research and to actively support the region’s venture community and area entrepreneurs. From the beginning, our approach has been to access technology in the centers of discovery versus centers of finance.

^top